These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9632040)

  • 1. Nefazodone and the treatment of panic.
    Berigan TR; Casas A; Harazin J
    J Clin Psychiatry; 1998 May; 59(5):256-7. PubMed ID: 9632040
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of open-label nefazodone treatment in patients with panic disorder.
    Papp LA; Coplan JD; Martinez JM; de Jesus M; Gorman JM
    J Clin Psychopharmacol; 2000 Oct; 20(5):544-6. PubMed ID: 11001239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antidepressants and CBT for panic disorder with agoraphobia.
    Coupland NJ
    J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
    [No Abstract]   [Full Text] [Related]  

  • 4. Discussion of "methodological controversies in the treatment of panic disorder".
    Klein DF
    Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid fade of antidepressant effect of nefazodone in bipolar depression.
    El-Mallakh RS
    J Clin Psychiatry; 1999 Aug; 60(8):559. PubMed ID: 10485645
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilot open-label study of nefazodone in panic disorder.
    Bystritsky A; Rosen R; Suri R; Vapnik T
    Depress Anxiety; 1999; 10(3):137-9. PubMed ID: 10604088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia.
    van den Hout M; Arntz A; Hoekstra R
    Behav Res Ther; 1994 May; 32(4):447-51. PubMed ID: 7910732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
    Thase ME; Rush AJ; Manber R; Kornstein SG; Klein DN; Markowitz JC; Ninan PT; Friedman ES; Dunner DL; Schatzberg AF; Borian FE; Trivedi MH; Keller MB
    J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated treatment of panic disorder.
    Rosenbaum JF; Pollock RA; Otto MW; Pollack MH
    Bull Menninger Clin; 1995; 59(2 Suppl A):A4-26. PubMed ID: 7795571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
    Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
    J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
    Oei TP; Llamas M; Evans L
    Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials.
    Spiegel DA; Bruce TJ
    Am J Psychiatry; 1997 Jun; 154(6):773-81. PubMed ID: 9167504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy].
    Boerner RJ
    Psychiatr Prax; 1995 Jan; 22(1):30-2. PubMed ID: 7892341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral treatment of panic disorders and agoraphobia.
    Craske MG; Rodriguez BI
    Prog Behav Modif; 1994; 29():1-26. PubMed ID: 8153022
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
    Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
    Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(2):110-1; author reply 111. PubMed ID: 12601232
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive therapy in panic disorder.
    Marks I; Basoglu M; Noshirvani H
    Br J Psychiatry; 1994 Oct; 165(4):556-9. PubMed ID: 7804686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.